Syringe and ampoule against the background of the Sputnik V logoBRUSSELS, Feb 9 The Sputnik V coronavirus vaccine in the European Union is not going well, but its admission to the EU market is still possible, Russian Permanent Representative to the European Union Vladimir Chizhov said in an interview with RIA Novosti. Answering a question about how the Russian vaccine is being evaluated in the European Union, he said: «It's not easy, to put it bluntly. It's a complex process, it's complicated organizationally, technically, legally, and politically. But it's going on.»»Sputnik V». All about the first Russian vaccine against coronavirus»I still believe that this (the recognition of the drug throughout the European Union — ed.) is possible, although I will not predict the timing,» Chizhov added. the gradual evaluation procedure in the European Medicines Agency (EMA), which approves medicines for centralized use in the European Union. As reported in January, the EMA continues its assessment and does not comment on the results of the work until the procedure is completed. Earlier, the deputy head of the Gamaleya Center, Denis Logunov, said that EMA specialists had given a positive opinion on the recognition of Sputnik V production standards and the conduct of clinical trials of the Russian vaccine against coronavirus.»Sputnik V» approved in 71 countries with a total population of 4 billion people, more than 50% of the world's population. In terms of the number of approvals received by state regulators, Sputnik V ranks second in the world. The effectiveness of the vaccine was 97.6% based on an analysis of data from 3.8 million vaccinated Russians, which is higher than the data published earlier by the medical journal The Lancet (91.6%), reported by the Russian Direct Investment Fund (RDIF) and Gamaleya Research Center. Data on the use of Sputnik V during vaccination of the population in a number of countries (Argentina, San Marino, Serbia, Hungary, Bahrain, Mexico, the United Arab Emirates and others) demonstrate that Sputnik V is one of the safest and most effective vaccines against coronavirus , RDIF reported.
